1.039
Schlusskurs vom Vortag:
$1.02
Offen:
$1.04
24-Stunden-Volumen:
235.96K
Relative Volume:
0.47
Marktkapitalisierung:
$110.48M
Einnahmen:
$238.26M
Nettoeinkommen (Verlust:
$-236.56M
KGV:
-0.6382
EPS:
-1.6281
Netto-Cashflow:
$27.06M
1W Leistung:
-0.48%
1M Leistung:
+45.06%
6M Leistung:
-16.53%
1J Leistung:
-75.00%
Definitive Healthcare Corp Stock (DH) Company Profile
Firmenname
Definitive Healthcare Corp
Sektor
Branche
Telefon
508-720-4224
Adresse
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Compare DH vs VEEV, BTSG, TEM, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp
|
1.035 | 108.88M | 238.26M | -236.56M | 27.06M | -1.6281 |
|
VEEV
Veeva Systems Inc
|
262.95 | 42.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
61.91 | 12.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
63.09 | 11.67B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
TXG
10 X Genomics Inc
|
66.88 | 8.55B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HQY
Healthequity Inc
|
93.77 | 7.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-09-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-31 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-17 | Herabstufung | Needham | Buy → Hold |
| 2024-01-05 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-04-19 | Eingeleitet | William Blair | Outperform |
| 2022-12-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-07-06 | Eingeleitet | Needham | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-02-24 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-12-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-10-11 | Eingeleitet | Barclays | Equal Weight |
| 2021-10-11 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-10-11 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-11 | Eingeleitet | Deutsche Bank | Hold |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-10-11 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-10-11 | Eingeleitet | Stifel | Buy |
Alle ansehen
Definitive Healthcare Corp Aktie (DH) Neueste Nachrichten
Definitive Healthcare Receives Going-Private Proposal from Advent International - Global Legal Chronicle
Definitive Healthcare stock draws $1.02 buyout offer from Advent By Investing.com - Investing.com Australia
Definitive Healthcare Corp. (DH) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Definitive Healthcare stock draws $1.02 buyout offer from Advent - Investing.com
Definitive Healthcare (DH) CFO stock withheld for RSU taxes - Stock Titan
Advent Proposed $1.02 Cash Take-Private of Definitive Healthcare: - HedgeCo.Net
Definitive Healthcare receives take-private offer from majority shareholder, names new CEO - The Business Journals
Definitive Healthcare Receives $1.02-Per-Share Going-Private Proposal From Advent - citybiz.co
DH Stock Jumps As AI Platform And EPS Beat Draw Trader Focus - StocksToTrade
Definitive Healthcare CorpKevin Coop Depar - Moomoo
Definitive Healthcare receives $1.02 buyout offer from Advent By Investing.com - Investing.com South Africa
Definitive Healthcare Shares Rise 13% After Advent International Submits $1.02-Per-Share Proposal - Yahoo Finance
Definitive Healthcare names Clay Ritchey as new CEO By Investing.com - Investing.com Nigeria
Definitive Healthcare receives $1.02 buyout offer from Advent - Investing.com
Definitive Healthcare Receives Acquisition Proposal From Advent International - marketscreener.com
Definitive Healthcare Receives $1.02 Per Share Going-Private Offer from Advent - Minichart
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International - The Manila Times
Definitive Healthcare stock surges 13% on Advent buyout offer - Investing.com India
Definitive Healthcare stock rises on Advent bid (DH:NASDAQ) - Seeking Alpha
Definitive Healthcare stock surges 13% on Advent buyout offer By Investing.com - Investing.com Nigeria
Definitive Healthcare Appoints Clay Ritchey as CEO - marketscreener.com
Definitive Healthcare names Clay Ritchey as new CEO - Investing.com
Jason Krantz Weighs Rollover in Advent Bid at Definitive Healthcare with 17.6% Stake - TradingView
A $1.02 cash bid could tie up most of Definitive Healthcare (DH) — see how much one insider now reports owning - Stock Titan
Advent International, L.P. Proposes Buyout at Definitive Healthcare with 58.5% Stake - TradingView
Advent makes non-binding cash bid for all Definitive Healthcare (NASDAQ: DH) shares - Stock Titan
Advent International, L.P. submitted a preliminary non-binding indication of interest to acquire an additional 20.38% stake in Definitive Healthcare Corp. (NasdaqGS:DH) for $22.2 million. - marketscreener.com
DH|Definitive Healthcare Corp|Price:0.754|Chg%:+0.033 - TradingKey
Definitive Healthcare Earnings Call: Profits Up, Sales Down - The Globe and Mail
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
Definitive Healthcare (DH) Q2 2026 Earnings Call - AOL.com
Definitive (DH) Update: Ends Lower by 1.95% at $0.70; Key Range: the Current Price Sits Inside the Supplied Technical Range in the Latest SessionElliott Wave Count - vinanet.vn
Definitive Healthcare posts a stellar 41.44% RO... - Pluang
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI) - The Globe and Mail
Deutsche Bank Adjusts Definitive Healthcare Price Target to $1 From $3, Maintains Hold Rating - marketscreener.com
DH Q2 2026 Earnings: EPS Beat Delivers 13.6% Surprise Despite Modest Share GainEarnings Deceleration Risk - vinanet.vn
Definitive Healthcare Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:DH) 2026-08-11 - Seeking Alpha
Definitive Healthcare Corp. Stock 12‑Month Price Target Cut to $1.7, Implies 143% Upside - TradingView
Morgan Stanley Adjusts Definitive Healthcare PT to $1.50 From $2.50, Maintains Equalweight Rating - marketscreener.com
Definitive Healthcare Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
Definitive Healthcare Reports Financial Results for Second Quarter 2026 - The Manila Times
Definitive Healthcare Corp (DH) (Q2 2026) Earnings Call Highlights: AI Platform Launch and ... - Yahoo Finance UK
Definitive Healthcare earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Definitive Healthcare revenue falls 9% in Q2, cash flow holds - scanx.trade
Earnings call transcript: Definitive Healthcare tops Q2 2026 EPS forecast By Investing.com - Investing.com Nigeria
Definitive Healthcare Q2 2026 slides: profit beats amid revenue decline - Investing.com
Earnings call transcript: Definitive Healthcare tops Q2 2026 EPS forecast - Investing.com
Definitive Healthcare Q2 Earnings Call Highlights - MarketBeat
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates - Yahoo Finance
Definitive Healthcare Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Definitive Healthcare (NASDAQ:DH) Releases Q3 2026 Earnings Guidance - MarketBeat
Finanzdaten der Definitive Healthcare Corp-Aktie (DH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):